Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases
about
Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: a multicenter registry studyThe association between peritoneal dialysis modality and peritonitis.Adverse outcomes among Aboriginal patients receiving peritoneal dialysis.Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysisThe effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study.Peritoneal adhesion: it can be life-threatening, and life-saving.Recent peritonitis associates with mortality among patients treated with peritoneal dialysis.The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial.Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis.Risk factors and outcome of contamination in patients on peritoneal dialysis--a single-center experience of 15 yearsConsensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.Is female sex really a risk factor for infectious death in peritoneal dialysis?Dialysate White Blood Cell Change after Initial Antibiotic Treatment Represented the Patterns of Response in Peritoneal Dialysis-Related Peritonitis.The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis.Peritoneal dialysis-related infections recommendations: 2010 update. What is new?Infectious complications in dialysis--epidemiology and outcomes.Successful antibiotic treatment of Pseudomonas stutzeri-induced peritonitis without peritoneal dialysis catheter removal in continuous ambulatory peritoneal dialysis.33 Years of Peritoneal Dialysis-Associated Peritonitis: A Single-Center Study in Japan.Continuous Quality Improvement Initiatives to Sustainably Reduce Peritoneal Dialysis-Related Infections in Australia and New Zealand.The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.Peritonitis and technique failure caused by Roseomonas mucosa in an adolescent infected with HIV on continuous cycling peritoneal dialysis.ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.Pseudomonas luteola peritonitis with favorable outcome in continuous peritoneal dialysis.The Relationship Between Presentation and the Time of Initial Administration of Antibiotics With Outcomes of Peritonitis in Peritoneal Dialysis Patients: The PROMPT Study.Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis.Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series.Peritoneal dialysis-related peritonitis: challenges and solutions.
P2860
Q30560814-BA4D075C-9EA4-4765-8664-1A660FD5B79DQ33715831-09F8C918-B6C3-4867-B931-508F421BF529Q34142626-B5447ECA-13A2-4259-9181-D4DEB421EE9FQ34182921-9DF8D4F4-BE82-4458-9061-68C42809FABAQ34306126-772E8FA6-BC75-4841-ABEE-3A620133523EQ34418363-5D8DC6A1-503A-42C9-9B87-C3F2C84931E4Q36109181-468C7397-7C3F-4371-B19F-C36CC03B9A63Q36474236-DE034E58-7A4F-4219-8E80-DFD62EFA9805Q36474262-0ABB1B17-7B83-48DC-A3FC-15AF0B00E8FDQ36474356-FC8E9649-ED7B-4972-A0C9-F06E2B08FDD7Q36474366-67641C19-A666-41AF-B007-63F70EC6A4A3Q37232259-832789AC-7349-4E5A-9AD7-4E480635F096Q37253215-F0A331B1-F9AE-4A71-B1C0-B9F153F1AEE1Q37669439-30FC6789-D001-470C-9B37-12F07DB789E9Q37899792-8F456ECC-B54D-41F8-B99F-A191B77EB731Q37969996-729B46C3-4281-4D21-8958-0C84019E8B65Q39996560-3CF02DE9-051A-4045-8AC7-B3E92228126EQ40312576-7DA241B6-0F6A-45B3-B832-195A4328B85CQ40530036-08FE8871-49C8-45F8-A2B1-C1E1EAC2F8DEQ41082058-AE04BBE8-EDC7-42EE-97D5-92838B40364AQ41580511-21CED1CC-CFA8-4C26-B6C1-F9E07AF97F75Q42104270-CFF886CB-5E53-4CC2-A38A-E02355348C9DQ43432940-66A1728F-7C4B-49B3-8FC2-EA453EE4CF73Q43488863-54FB4CD6-FD02-44D3-BDDA-FEFC26F3C38DQ44507201-BD978779-53D7-465B-B5AC-5AAF42306E68Q47786464-45B7E6FF-7C03-411E-8D3A-AAD038805209Q55354083-4D422EE2-085D-441D-B54E-63063D7C0614Q55399642-4DCDEF0D-AC44-4FC9-AAEE-D0A1A39D68B2
P2860
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases
@en
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases.
@nl
type
label
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases
@en
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases.
@nl
prefLabel
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases
@en
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases.
@nl
P2093
P2860
P50
P356
P1476
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases
@en
P2093
Brian Siva
Fiona G Brown
Kathryn J Wiggins
Kym M Bannister
Stephen P McDonald
P2860
P304
P356
10.2215/CJN.00010109
P577
2009-04-30T00:00:00Z